Vizient, Inc.

290 E John Carpenter Freeway, Irving, TX 75062
Uncategorized
Uncategorized
back to directoryBack to Directory

Related Posts:

VIZIENT, INC.: Expresses Concern with FDA Policy on Naming of Biologic Medications
VIZIENT, INC.: Expresses Concern with FDA Policy on Naming of Biologic Medications

May 7, 2019

Vizient, Inc. today submitted comments to the Food and Drug Administration (FDA) in response to its published draft guidance on the nonproprietary naming of biological products.

Read more →

Trending

BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information
LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity
KING & SPALDING: FDA and Life Sciences Team Adds Partner in Washington
FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer’s Disease
ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients

The Weekly Newsletter

Sign-up for the Weekly Newsletter from FDA Reporter.